Kairos Therapeutics' Acquisition

Kairos Therapeutics was acquired by Zymeworks on March 22, 2016.

Kairos Therapeutics is a biopharmaceutical company with a proprietary next-generation antibody-drug conjugate platform based on novel toxin, linker, and site-specific conjugation technology. This tech…

Articles about Kairos Therapeutics' Acquisition: